Cargando…
Guide to Selection of Fluoroquinolones in Patients with Lower Respiratory Tract Infections
Newer fluoroquinolones such as levofloxacin, moxifloxacin, gatifloxacin and gemifloxacin have several attributes that make them excellent choices for the therapy of lower respiratory tract infections. In particular, they have excellent intrinsic activity against Streptococcus pneumoniae, Haemophilus...
Autores principales: | Shams, Wael E., Evans, Martin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100689/ https://www.ncbi.nlm.nih.gov/pubmed/15892589 http://dx.doi.org/10.2165/00003495-200565070-00004 |
Ejemplares similares
-
Decalogue for the selection of oral antibiotics for lower respiratory tract infections
por: Cantón, Rafael, et al.
Publicado: (2022) -
High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017) -
Lower Respiratory Tract Infections
por: Humphreys, Hilary, et al.
Publicado: (2012) -
Infections of the lower respiratory tract
por: Mandell, Lionel A., et al.
Publicado: (2010) -
LOWER RESPIRATORY TRACT INFECTIONS IN ELDERLY PATIENTS WITH ASTHMA
por: Hunter, Alan J., et al.
Publicado: (1997)